Literature DB >> 13410182

The treatment of the nephrotic syndrome with steroids in children and adults.

K LANGE, R STRANG, L B SLOBODY, E J WENK.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; CORTISONE/therapeutic use; NEPHROTIC SYNDROME/therapy

Mesh：

Substances：

Year:  1957        PMID： 13410182     DOI： 10.1001/archinte.1957.00260050088011

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  8 in total

1.  STEROIDS IN TREATMENT OF THE NEPHROTIC SYNDROME IN ADULTS.

Authors:  H GOTZE; W T MCCAUGHEY; R A WOMERSLEY
Journal:  Br Med J       Date:  1964-02-08

2.  The nephrotic syndrome in adults.

Authors:  E L BECKER
Journal:  Bull N Y Acad Med       Date:  1962-01

3.  Regression of amyloidosis secondary to rheumatoid arthritis.

Authors:  R A PARKINS; E G BYWATERS
Journal:  Br Med J       Date:  1959-02-28

4.  Variations in serum complement in the nephrotic syndrome and other forms of renal disease.

Authors:  H A ELLIS; K W WALTON
Journal:  Immunology       Date:  1958-07       Impact factor: 7.397

5.  Immunoconglutinin and complement changes in steroid sensitive relapsing nephrotic syndrome of children.

Authors:  J L Ngu; T M Barratt; J F Soothill
Journal:  Clin Exp Immunol       Date:  1970-01       Impact factor: 4.330

6.  Differential protein clearances in Indian children with the nephrotic syndrome.

Authors:  R K Chandra; S S Manchanda; R N Srivastava; J F Soothill
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

7.  Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Eur J Pediatr       Date:  1981-02       Impact factor: 3.183

Review 8.  Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance.

Authors:  Kenneth V Lieberman; Anna Pavlova-Wolf
Journal:  J Nephrol       Date:  2016-04-16       Impact factor: 3.902
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.